Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-16 | Andrew Hack, M.D., Ph.D. Dr. Hack has served as a member of our Board since August 2019 and currently serves as Interim Chairperson of the Board. ... The following table shows for the fiscal year ended December 31, 2020, certain information with respect to the cash compensation of all non-employee directors of the Company: ... Andrew A. F. Hack, M.D., Ph.D. Fees Earned or Paid in Cash $85,000, Option Awards $62,376, Total $147,376. |
| 2023-04-13 | Andrew A. F. Hack, M.D., Ph.D. Dr. Hack has been a member of our Board since August 2019. ... Our Board believes that Dr. Hack’s financial background and extensive and diverse experience in the life sciences industry qualifies him to serve on our Board. |
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-30 | "Dr. Hack started his investment career at Banc of America Securities... He was also a co-founder of Reify Corporation, a life science tools and drug discovery company. Dr. Hack received a B.A. in Biology, an M.D. and a Ph.D." |
| 2019-04-23 | "Dr. Hack has served as a Managing Director of Bain Capital Life Sciences... Before joining Bain Capital, Dr. Hack was the Chief Financial Officer of Editas Medicine... He received his B.A. in biology... M.D. and Ph.D." |
| 2020-04-20 | “Dr. Hack received his B.A. in biology with special honors from the University of Chicago, where he also received his M.D. and Ph.D...” |
| 2021-04-27 | "We believe that Dr. Hack’s financial background, as well as his experience in the biotechnology sector and his medical background, qualify him to serve as a member of our Board of Directors." |
| 2022-04-29 | "We believe that Dr. Hack’s financial and medical background, as well as his experience in the biotechnology sector, qualify him to serve as a member of our Board of Directors." |
| 2023-04-28 | "Dr. Hack received an A.B. in biology with special honors, an M.D. and a Ph.D. in molecular genetics and cell biology from the University of Chicago. We believe that Dr. Hack’s financial and medical background, as well as his experience in the biotechnology sector, qualify him to serve as a member of our Board of Directors." |
| 2024-04-26 | "Dr. Hack received an A.B. in biology with special honors, an M.D. and a Ph.D. in molecular genetics and cell biology from the University of Chicago." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-06-10